Shalini Sharp
Equibles does not estimate personal net worth.
About Shalini Sharp
Earlier roles on record: CFO at Ultragenyx Pharmaceutical Inc. (RARE) until November 2, 2020. The proxy statement of Ultragenyx Pharmaceutical Inc. reports total compensation of $793,249 for Shalini Sharp in fiscal 2020, including a base salary of $499,638. Disclosed compensation is on record for 4 fiscal years. Shalini Sharp has spoken on 3 earnings calls across 1 company, most recently for Ultragenyx Pharmaceutical Inc. on October 27, 2020. The companies whose calls Shalini Sharp spoke on are classified in the Healthcare sector.
Shalini Sharp on recent calls
“Well, thank you so much, Emil, and good afternoon to everybody. I am delighted to join you all for our last quarterly conference call.”
“We issued a press release earlier today that included a financial update, which I will briefly summarize. Total revenue for the 3 months ending June 30, 2020, was $61.7 million.”
“Earlier today, we issued a press release that included a financial update, which I will briefly summarize. Total revenue for the three months ending March 31, 2020, was $36.3 million.”
Affiliation history
-
Start not stated–2020-11-02
Company network
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2020 | Ultragenyx Pharmaceutical Inc. (RARE) | Former Chief Financial Officer and Executive Vice President | $499,638 | $793,249 |
| 2019 | Ultragenyx Pharmaceutical Inc. (RARE) | Former Chief Financial Officer and Executive Vice President | $484,548 | $2,572,184 |
| 2018 | Ultragenyx Pharmaceutical Inc. (RARE) | Former Chief Financial Officer and Executive Vice President | $470,435 | $2,027,960 |
| 2017 | Ultragenyx Pharmaceutical Inc. (RARE) | Chief Financial Officer and Executive Vice President | $455,785 | $2,642,719 |